By Counterforce Health Team in Darzalex / Darzalex Faspro (daratumumab) —

Denied for Darzalex/Darzalex Faspro by Cigna in New Jersey? Complete Appeal Guide (Templates & Timelines)

Answer Box: Your Path to Approval

Cigna requires prior authorization for Darzalex/Darzalex Faspro in New Jersey, with appeals available through internal review (180 days) and New Jersey's IHCAP external review via Maximus Federal Services. Most denials stem from incomplete prior therapy documentation or non-formulary status. Start today: Gather your denial letter, clinical records, and prior treatment history. Submit internal appeal with NCCN guidelines within 180 days, then file external review at njihcap.maximus.com if denied.

Table of Contents

Understanding Your Denial

Before appealing, decode your denial letter to identify the specific reason. Cigna typically denies Darzalex/Darzalex Faspro for these reasons:

  • Missing prior therapy documentation - Need records showing failed proteasome inhibitor (bortezomib) and immunomodulatory drug (lenalidomide)
  • Non-formulary status - Drug not on your plan's preferred list
  • Step therapy requirements - Must try cheaper alternatives first
  • Incomplete clinical information - Missing multiple myeloma staging, ICD-10 codes, or treatment history
  • Site of care restrictions - May require specific infusion centers

Look for the denial code on your Explanation of Benefits (EOB) and note the appeal deadline - typically 180 days from the denial date.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Darzalex formulations Cigna PA Form Library Cigna Policy
Formulary Tier Specialty Tier 4 (20-40% coinsurance) Cigna member portal Plan documents
Step Therapy Prior PI + IMiD failure required PA form documentation Cigna Oncology Policy
Specialty Pharmacy Dispensed through Accredo/Express Scripts Automatic enrollment post-approval Coverage policy
Internal Appeals 180 days from denial Written submission required Cigna appeals process
External Review 4 months after final internal denial NJ IHCAP Portal NJ DOBI

Step-by-Step: Fastest Path to Approval

1. Gather Required Documents (Patient/Clinic)

  • Insurance card and member ID
  • Complete denial letter with reason codes
  • Multiple myeloma diagnosis confirmation (pathology report)
  • Prior treatment records showing failed therapies
  • Current lab values and imaging
  • Timeline: 1-2 days to collect

2. Complete Cigna Prior Authorization Form (Oncologist)

  • Download Cigna Darzalex PA form
  • Include ICD-10 codes (C90.00-C90.02 for multiple myeloma)
  • Document prior bortezomib and lenalidomide exposure with failure reasons
  • Submit via: CoverMyMeds portal or fax (855) 840-1678
  • Timeline: 15 business days (standard), 72 hours (urgent)

3. Track Authorization Status (Patient/Clinic)

  • Monitor via Cigna provider portal
  • Call Provider Services: 1-800-88-CIGNA (882-4462)
  • Timeline: Decision within stated timeframe

4. If Denied: File Internal Appeal (Patient/Clinic)

  • Submit written appeal within 180 days
  • Include NCCN guidelines showing Category 1 recommendation
  • Request peer-to-peer review with oncology medical director
  • Timeline: 30 days for pre-service, 60 days for post-service

5. External Review via New Jersey IHCAP (Patient)

  • File at njihcap.maximus.com within 4 months
  • Submit after completing internal appeals
  • Timeline: 45 days for decision, 48 hours if expedited

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documents
"Insufficient prior therapy documentation" Submit complete treatment timeline with dates, doses, outcomes Prior therapy records, physician notes, lab values showing progression
"Does not meet step therapy requirements" Document contraindications or failures of required prior drugs Allergy records, intolerance documentation, progression notes
"Not medically necessary" Include NCCN Category 1 guidelines and clinical rationale NCCN Multiple Myeloma Guidelines, FDA label, peer-reviewed studies
"Non-formulary drug" Request formulary exception with medical justification Formulary exception form, clinical necessity letter
"Experimental/investigational" Cite FDA approval and established use in guidelines FDA label, NCCN compendium, clinical trial data

Appeals Playbook for Cigna in New Jersey

Internal Appeal Process

Level 1 Appeal (First Internal Review)

  • Deadline: 180 days from denial
  • Submission: Written request to Cigna National Appeals Unit
    • Address: PO Box 188011, Chattanooga, TN 37422
    • Fax: Check current provider manual for updated number
  • Required Elements: Patient ID, denial reference, clinical justification, supporting documents
  • Timeline: 30 days (pre-service), 60 days (post-service)

Level 2 Appeal (Second Internal Review)

  • Deadline: 60 days from Level 1 denial
  • Process: New reviewer, often physician
  • Enhanced documentation: Additional clinical evidence, peer-reviewed literature

Expedited Appeals

For urgent cases where delay could jeopardize health:

  • Timeline: 72 hours for decision
  • Process: Mark all submissions "EXPEDITED - URGENT"
  • Justification required: Clinical rationale for urgency
From our advocates: "We've seen Cigna overturn about 80% of Darzalex denials when appeals include complete prior therapy documentation and NCCN Category 1 evidence. The key is addressing the specific denial reason with targeted clinical evidence rather than submitting generic appeals."

Medical Necessity Letter Template

Use this template on physician letterhead, customized for your patient's specific situation:

[Date]
Cigna Medical Review Department
[Appeal Reference Number]

Re: Medical Necessity Appeal - Darzalex (daratumumab)
Patient: [Name, DOB, Member ID]
Diagnosis: Multiple Myeloma (ICD-10: C90.00)

Dear Medical Director,

I am requesting authorization for Darzalex (daratumumab) 16 mg/kg IV weekly x 8 weeks, then every 2 weeks x 16 weeks, then monthly, in combination with lenalidomide and dexamethasone (DRd regimen) for [Patient Name].

CLINICAL JUSTIFICATION:
1. NCCN Guidelines Compliance: DRd is NCCN Category 1 preferred therapy for newly diagnosed multiple myeloma patients ineligible for transplant (NCCN Guidelines v.3.2024, page MM-4).

2. Prior Therapy History: Patient previously received:
   - Bortezomib + dexamethasone (6 cycles, discontinued due to peripheral neuropathy)
   - Lenalidomide maintenance (18 months, disease progression with rising M-protein)

3. Current Status: Recent bone marrow biopsy confirms relapsed multiple myeloma with [specific cytogenetics]. ECOG performance status 1, adequate organ function.

4. Medical Necessity: Patient meets all Cigna coverage criteria per Oncology Policy. No contraindications to daratumumab therapy.

Supporting documentation attached: NCCN guidelines excerpt, pathology report, prior treatment records, current labs.

Please approve this medically necessary treatment. I am available for peer-to-peer discussion at [phone/email].

Sincerely,
[Physician Name, Credentials]
[DEA/NPI numbers]

Peer-to-Peer Review Strategy

Requesting P2P Review

  • Include request in initial appeal letter
  • Call Provider Services: 1-800-88-CIGNA to escalate
  • Timeline: Usually scheduled within 7-14 days of appeal submission

Key Talking Points for Medical Director Discussion

  1. Patient specifics: Cigna member ID, exact denial reason, multiple myeloma subtype
  2. Guidelines alignment: NCCN Category 1 recommendation for patient's specific situation
  3. Prior therapy failures: Detailed history with dates and failure reasons
  4. Clinical urgency: Disease progression risk if treatment delayed
  5. Alternatives exhausted: Why other options are inappropriate or contraindicated

Success Factors

  • Have complete medical records available
  • Reference specific Cigna policy language
  • Emphasize guideline-concordant care
  • Document functional status and quality of life impact

New Jersey External Review Process

If Cigna denies your internal appeals, New Jersey's Independent Health Care Appeals Program (IHCAP) provides binding external review.

Eligibility Requirements

  • Completed Cigna's internal appeal process (both levels)
  • Denial based on medical necessity, experimental/investigational determination, or similar coverage issue
  • New Jersey-regulated insurance plan
  • Filed within 4 months of final internal denial

How to File

  1. Online (Preferred): Register at njihcap.maximus.com
  2. Required Documents:
    • Cigna denial letters (all levels)
    • Consent and authorization forms
    • Medical records supporting the request
    • Provider letter of medical necessity

Process Timeline

  • Preliminary Review: 5 business days to confirm eligibility
  • Full Review: 45 days for standard cases, 48 hours for expedited
  • Cost: Free to patients (insurers pay all fees)

Contact Information

Cost Support Options

While working through the approval process, explore these financial assistance programs:

Manufacturer Support

  • Janssen CarePath: Copay assistance and patient support services
  • Website: jnjwithme.com
  • Phone: 1-844-553-2792

Foundation Grants

  • Multiple Myeloma Research Foundation: Patient assistance programs
  • Leukemia & Lymphoma Society: Co-pay assistance for eligible patients
  • CancerCare: Financial assistance and counseling

State Resources

  • New Jersey Cancer Education and Early Detection Program: May provide navigation assistance
  • NJ FamilyCare: Medicaid expansion for eligible individuals

When navigating insurance denials and appeals, Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. The platform analyzes denial letters and plan policies to identify the specific denial basis, then drafts point-by-point rebuttals aligned to the payer's own rules, incorporating the right clinical evidence and procedural requirements.

Frequently Asked Questions

How long does Cigna prior authorization take for Darzalex in New Jersey? Standard PA decisions take 15 business days, while urgent requests are processed within 72 hours. Track status via the Cigna provider portal or by calling 1-800-88-CIGNA.

What if Darzalex is non-formulary on my Cigna plan? Request a formulary exception by submitting clinical documentation showing medical necessity. Include evidence that formulary alternatives are inappropriate, contraindicated, or have failed.

Can I get an expedited appeal if my condition is worsening? Yes. Mark all submissions "EXPEDITED - URGENT" and provide clinical justification for why delay would jeopardize your health. Expedited appeals are decided within 72 hours.

Does step therapy apply if I failed treatments in another state? Yes. Prior therapy records from any state count toward step therapy requirements. Ensure all documentation is included in your PA submission.

What happens if both internal appeals are denied? You can file for external review through New Jersey's IHCAP program within 4 months. This provides binding review by independent medical experts.

How much does Darzalex cost with Cigna coverage? As a specialty tier drug, expect 20-40% coinsurance after meeting your deductible. Exact costs depend on your specific plan. Check the Cigna member portal for your copay details.

Can my doctor help with the appeal process? Yes. Physicians can submit appeals on your behalf and participate in peer-to-peer reviews with Cigna medical directors. Provider involvement significantly improves appeal success rates.

What if I need Darzalex Faspro specifically instead of IV Darzalex? Include clinical justification for the subcutaneous formulation in your PA request, such as poor IV access, infusion reactions, or patient preference for home administration.

Sources & Further Reading

For additional support navigating complex insurance appeals, Counterforce Health provides specialized assistance in turning denials into successful authorizations through evidence-based appeal strategies.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for guidance specific to your situation. Coverage policies and procedures may change; verify current requirements with Cigna and New Jersey regulatory authorities.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.